经皮耳迷走神经刺激治疗功能性消化不良有效:一项多中心随机对照研究
本研究纳入符合罗马IV标准且改良FD症状日记评分≥10的连续FD患者300例,随机分为10Hz taVNS组(101例)、25Hz taVNS组(99例)和假刺激组(100例),每日治疗30分钟、每日两次、持续4周。主要结局为第4周应答率,10Hz组和25Hz组均高于假刺激组(81.2% vs 75.9% vs 47%,均P<0.001);充分缓解率同样较高(85.1% vs 80.8% vs 67%,均P<0.05),两刺激组间无显著差异(均P>0.05)。
要点
- 4周taVNS(10Hz和25Hz)可提高FD患者第4周应答率和充分缓解率,优于假刺激。
- 10Hz与25Hz两组在应答率和充分缓解率上无显著差异(均P>0.05)。
- taVNS疗效在随访第8周和第12周仍持续,不良事件均为轻度且三组相当(1%-3%)。
核心结论
- 4周taVNS(10Hz和25Hz)对成人功能性消化不良治疗有效且安全。
研究设计与样本
- 多中心随机对照研究,连续纳入符合罗马IV标准且改良FD症状日记评分≥10的FD患者300例。
- 随机分为10Hz taVNS组(V10,n=101)、25Hz taVNS组(V25,n=99)和假刺激组(n=100),每日治疗30分钟、每日两次、持续4周。
主要发现
- 第4周应答率:V10组81.2% vs V25组75.9% vs 假刺激组47%,V10和V25分别与假刺激组比较均P<0.001。
- 第4周充分缓解率:V10组85.1% vs V25组80.8% vs 假刺激组67%,V10和V25分别与假刺激组比较均P<0.05。
- V10与V25在应答率和充分缓解率上均无显著差异(均P>0.05)。
- taVNS(10Hz和25Hz)疗效在随访第8周和第12周持续。
- 不良事件均为轻度,三组间相当(1%-3%)。
关键数值与推荐
- 主要结局为第4周应答率,定义为改良FD症状日记评分较基线降低≥5分的患者比例。
- 次要结局包括充分缓解率和不良事件。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Vagal nerve stimulation (VNS) can be used to modulate gastrointestinal motility, inflammation, and nociception. However, it remains unclear whether VNS is effective in adult patients with functional dyspepsia (FD). We investigated the effectiveness of transcutaneous auricular VNS (taVNS) in patients with FD. METHODS: Consecutive patients with FD meeting Rome IV criteria with modified FD Symptom Diary score ≥10 were enrolled. Patients were randomly allocated to 10-Hz taVNS (V10 group), 25-Hz taVNS (V25 group), or sham group, with 30 minutes of treatment twice a day for 4 weeks. The primary outcome was the response rate at week 4, defined as the proportion of patients whose modified FD Symptom Diary score was reduced ≥5 when compared with the baseline. Secondary outcomes included adequate relief rate and adverse events. RESULTS: A total of 300 patients were randomized to V10 (n = 101), V25 (n = 99), and sham groups (n = 100). After 4 weeks of treatment, V10 and V25 groups had a higher response rate (81.2% vs 75.9% vs 47%, both P < 0.001) and adequate relief rate (85.1% vs 80.8% vs 67%, both P < 0.05) compared with the sham group. There was no significant difference between V10 and V25 in response rate and adequate relief rate (both P > 0.05). The efficacy of taVNS (both 10 and 25 Hz) lasted at week 8 and week 12 during follow-up period. Adverse events were all mild and comparable among the 3 groups (1%-3%). DISCUSSION: Our study firstly showed that 4-week taVNS (both 10 and 25 Hz) was effective and safe for the treatment of adult FD ( clinicaltrials.gov number: NCT04668534).
引用
- Shi X, Zhao L, Luo H, et al. Transcutaneous Auricular Vagal Nerve Stimulation Is Effective for the Treatment of Functional Dyspepsia: A Multicenter, Randomized Controlled Study. Am J Gastroenterol. 2023. PMID: 37787432. doi:10.14309/ajg.0000000000002548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。